The newly prequalified vaccine, TAK-003 is developed by a multinational pharmaceutical company, Takeda as the second dengue ...
The World Health Organization (WHO) has granted prequalification to a new dengue vaccine, TAK-003, on 10th of May this year.
TAK-003 vaccine is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue.
Press Release - A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024.
The World Health Organization (WHO) said it had prequalified the second dengue vaccine, TAK-003 as a new weapon in the fight ...
The World Health Organisation (WHO) prequalified a new dengue vaccine TAK-003 on May 10. TAK-003, developed by Takeda, is ...
The World Health Organisation (WHO) this week pre-qualified a new vaccine for a mosquito-borne disease called –Dengue, which ...
Dengue fever is an illness that you get from a mosquito bite carrying one of four types of dengue virus(DENV). Found in ...
WHO approves TAK-003 (Qdenga) as 2nd dengue vaccine for children aged 6-16 in high-burden areas. Takeda in talks to launch in ...
Amidst the persistent global threat of dengue fever, a breakthrough has emerged with WHO granting pre-qualification to a new vaccine for the mosquito-borne disease. This significant development marks ...
The public health experts also highlighted the importance of larval elimination to tackle the spread of dengue.
The governors pointed out shortages of essential vaccines routinely administered to newborns and children under five, ...